We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
DexCom
DXCM
$30.2B
| $27K | ﹤0.01% |
+215
| New | +$22K |
2023 Q4
0 quarters
|
|
802
Exelon
EXC
$44.5B
| $27K | ﹤0.01% |
758
| – | – |
2022 Q1
7 quarters
|
|
803
Schwab Fundamental US Small Company Index ETF
FNDA
$8.83B
| $27K | ﹤0.01% |
972
| – | – |
2022 Q4
4 quarters
|
|
804
Barrick Mining
B
$67.2B
| $27K | ﹤0.01% |
1,500
| – | – |
2023 Q3
1 quarter
|
|
805
PIMCO Corporate & Income Opportunity Fund
PTY
$2.38B
| $27K | ﹤0.01% |
2,000
| – | – |
2022 Q1
7 quarters
|
|
806
RBC Bearings
RBC
$16B
| $27K | ﹤0.01% |
96
| – | – |
2022 Q2
6 quarters
|
|
807
Sanofi
SNY
$98.2B
| $27K | ﹤0.01% |
540
| – | – |
2022 Q1
7 quarters
|
|
808
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $27K | ﹤0.01% |
287
-56
| -16% | -$5.27K |
2022 Q1
7 quarters
|
|
809
BlackRock Limited Duration Income Trust
BLW
$451M
| $26K | ﹤0.01% |
1,900
| – | – |
2022 Q1
7 quarters
|
|
810
CrowdStrike
CRWD
$246B
| $26K | ﹤0.01% |
400
| – | – |
2022 Q1
7 quarters
|
|
811
Houlihan Lokey
HLI
$9B
| $26K | ﹤0.01% |
217
| – | – |
2022 Q2
6 quarters
|
|
812
Nucor
NUE
$60.2B
| $26K | ﹤0.01% |
147
| – | – |
2022 Q1
7 quarters
|
|
813
Royal Caribbean
RCL
$77.3B
| $26K | ﹤0.01% |
200
| – | – |
2022 Q1
7 quarters
|
|
814
Western Digital
WDC
$142B
| $26K | ﹤0.01% |
662
| – | – |
2023 Q2
2 quarters
|
|
815
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$487M
| $26K | ﹤0.01% |
3,000
| – | – |
2022 Q1
7 quarters
|
|
816
WidePoint Corp
WYY
$61.9M
| $26K | ﹤0.01% |
11,825
| – | – |
2022 Q1
7 quarters
|
|
817
Bank of America Depository Shares Series GG
BAC.PRB
$1.19B
| $25K | ﹤0.01% |
+1,000
| New | +$24.1K |
2023 Q4
0 quarters
|
|
818
Direxion Daily Healthcare Bull 3X ETF
CURE
$192M
| $25K | ﹤0.01% |
245
| – | – |
2022 Q1
7 quarters
|
|
819
Fifth Third Bancorp Depositary Shares Perpetual Class B Preferred Stock Series A
FITB.PRA
$179M
| $25K | ﹤0.01% |
+1,000
| New | +$23.4K |
2023 Q4
0 quarters
|
|
820
First Trust Senior Loan Fund ETF
FTSL
$2.47B
| $25K | ﹤0.01% |
545
| – | – |
2022 Q2
6 quarters
|
|
821
VanEck Gold Miners ETF
GDX
$26.4B
| $25K | ﹤0.01% |
800
| – | – |
2023 Q3
1 quarter
|
|
822
iShares MSCI India ETF
INDA
$5.82B
| $25K | ﹤0.01% |
500
| – | – |
2023 Q2
2 quarters
|
|
823
Kratos Defense & Security Solutions
KTOS
$7.27B
| $25K | ﹤0.01% |
1,200
| – | – |
2022 Q1
7 quarters
|
|
824
Lincoln National
LNC
$7.77B
| $25K | ﹤0.01% |
915
-70
| -7% | -$1.68K |
2022 Q1
7 quarters
|
|
825
Middleby
MIDD
$5.03B
| $25K | ﹤0.01% |
167
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.